nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—Hyponatraemia—Doxorubicin—ovarian cancer	0.00165	0.00165	CcSEcCtD
Milnacipran—Loss of consciousness—Paclitaxel—ovarian cancer	0.00164	0.00164	CcSEcCtD
Milnacipran—Mediastinal disorder—Docetaxel—ovarian cancer	0.00164	0.00164	CcSEcCtD
Milnacipran—Liver function test abnormal—Epirubicin—ovarian cancer	0.00164	0.00164	CcSEcCtD
Milnacipran—Rash—Melphalan—ovarian cancer	0.00163	0.00164	CcSEcCtD
Milnacipran—Dermatitis—Melphalan—ovarian cancer	0.00163	0.00163	CcSEcCtD
Milnacipran—Chills—Docetaxel—ovarian cancer	0.00163	0.00163	CcSEcCtD
Milnacipran—Asthenia—Vinorelbine—ovarian cancer	0.00162	0.00163	CcSEcCtD
Milnacipran—Dry skin—Epirubicin—ovarian cancer	0.00162	0.00163	CcSEcCtD
Milnacipran—Convulsion—Paclitaxel—ovarian cancer	0.00162	0.00162	CcSEcCtD
Milnacipran—Migraine—Doxorubicin—ovarian cancer	0.00161	0.00162	CcSEcCtD
Milnacipran—Hypertension—Paclitaxel—ovarian cancer	0.00161	0.00161	CcSEcCtD
Milnacipran—Pruritus—Vinorelbine—ovarian cancer	0.0016	0.0016	CcSEcCtD
Milnacipran—Breast disorder—Epirubicin—ovarian cancer	0.0016	0.0016	CcSEcCtD
Milnacipran—Mental disorder—Docetaxel—ovarian cancer	0.00159	0.00159	CcSEcCtD
Milnacipran—Chest pain—Paclitaxel—ovarian cancer	0.00159	0.00159	CcSEcCtD
Milnacipran—Anxiety—Paclitaxel—ovarian cancer	0.00158	0.00158	CcSEcCtD
Milnacipran—Malnutrition—Docetaxel—ovarian cancer	0.00158	0.00158	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00158	0.00158	CcSEcCtD
Milnacipran—Nausea—Topotecan—ovarian cancer	0.00157	0.00157	CcSEcCtD
Milnacipran—Dry mouth—Paclitaxel—ovarian cancer	0.00155	0.00156	CcSEcCtD
Milnacipran—Diarrhoea—Vinorelbine—ovarian cancer	0.00155	0.00155	CcSEcCtD
Milnacipran—Dysgeusia—Docetaxel—ovarian cancer	0.00155	0.00155	CcSEcCtD
Milnacipran—Abdominal distension—Epirubicin—ovarian cancer	0.00154	0.00154	CcSEcCtD
Milnacipran—Nausea—Melphalan—ovarian cancer	0.00154	0.00154	CcSEcCtD
Milnacipran—Liver function test abnormal—Doxorubicin—ovarian cancer	0.00151	0.00151	CcSEcCtD
Milnacipran—Infection—Paclitaxel—ovarian cancer	0.00151	0.00151	CcSEcCtD
Milnacipran—Dry skin—Doxorubicin—ovarian cancer	0.0015	0.0015	CcSEcCtD
Milnacipran—Shock—Paclitaxel—ovarian cancer	0.0015	0.0015	CcSEcCtD
Milnacipran—Dizziness—Vinorelbine—ovarian cancer	0.0015	0.0015	CcSEcCtD
Milnacipran—Nervous system disorder—Paclitaxel—ovarian cancer	0.00149	0.0015	CcSEcCtD
Milnacipran—Angina pectoris—Epirubicin—ovarian cancer	0.00149	0.00149	CcSEcCtD
Milnacipran—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00149	0.00149	CcSEcCtD
Milnacipran—Tachycardia—Paclitaxel—ovarian cancer	0.00149	0.00149	CcSEcCtD
Milnacipran—Breast disorder—Doxorubicin—ovarian cancer	0.00148	0.00148	CcSEcCtD
Milnacipran—Skin disorder—Paclitaxel—ovarian cancer	0.00148	0.00148	CcSEcCtD
Milnacipran—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00147	0.00147	CcSEcCtD
Milnacipran—Anorexia—Paclitaxel—ovarian cancer	0.00145	0.00145	CcSEcCtD
Milnacipran—Vomiting—Vinorelbine—ovarian cancer	0.00144	0.00144	CcSEcCtD
Milnacipran—Dysuria—Epirubicin—ovarian cancer	0.00143	0.00143	CcSEcCtD
Milnacipran—Neutropenia—Epirubicin—ovarian cancer	0.00143	0.00143	CcSEcCtD
Milnacipran—Rash—Vinorelbine—ovarian cancer	0.00143	0.00143	CcSEcCtD
Milnacipran—Dermatitis—Vinorelbine—ovarian cancer	0.00143	0.00143	CcSEcCtD
Milnacipran—Abdominal distension—Doxorubicin—ovarian cancer	0.00143	0.00143	CcSEcCtD
Milnacipran—Hypotension—Paclitaxel—ovarian cancer	0.00142	0.00142	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.00142	0.00142	CcSEcCtD
Milnacipran—Headache—Vinorelbine—ovarian cancer	0.00142	0.00142	CcSEcCtD
Milnacipran—Syncope—Docetaxel—ovarian cancer	0.00142	0.00142	CcSEcCtD
Milnacipran—Leukopenia—Docetaxel—ovarian cancer	0.00142	0.00142	CcSEcCtD
Milnacipran—Pollakiuria—Epirubicin—ovarian cancer	0.00141	0.00142	CcSEcCtD
Milnacipran—Palpitations—Docetaxel—ovarian cancer	0.0014	0.0014	CcSEcCtD
Milnacipran—Loss of consciousness—Docetaxel—ovarian cancer	0.00139	0.00139	CcSEcCtD
Milnacipran—Weight decreased—Epirubicin—ovarian cancer	0.00138	0.00139	CcSEcCtD
Milnacipran—Angina pectoris—Doxorubicin—ovarian cancer	0.00138	0.00138	CcSEcCtD
Milnacipran—Insomnia—Paclitaxel—ovarian cancer	0.00138	0.00138	CcSEcCtD
Milnacipran—Convulsion—Docetaxel—ovarian cancer	0.00137	0.00137	CcSEcCtD
Milnacipran—Paraesthesia—Paclitaxel—ovarian cancer	0.00137	0.00137	CcSEcCtD
Milnacipran—Hypertension—Docetaxel—ovarian cancer	0.00137	0.00137	CcSEcCtD
Milnacipran—Dyspnoea—Paclitaxel—ovarian cancer	0.00136	0.00136	CcSEcCtD
Milnacipran—Somnolence—Paclitaxel—ovarian cancer	0.00135	0.00136	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00135	0.00135	CcSEcCtD
Milnacipran—Chest pain—Docetaxel—ovarian cancer	0.00135	0.00135	CcSEcCtD
Milnacipran—Nausea—Vinorelbine—ovarian cancer	0.00134	0.00135	CcSEcCtD
Milnacipran—Dyspepsia—Paclitaxel—ovarian cancer	0.00134	0.00134	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00134	0.00134	CcSEcCtD
Milnacipran—Urinary tract infection—Epirubicin—ovarian cancer	0.00133	0.00133	CcSEcCtD
Milnacipran—Neutropenia—Doxorubicin—ovarian cancer	0.00132	0.00133	CcSEcCtD
Milnacipran—Dysuria—Doxorubicin—ovarian cancer	0.00132	0.00133	CcSEcCtD
Milnacipran—Decreased appetite—Paclitaxel—ovarian cancer	0.00132	0.00133	CcSEcCtD
Milnacipran—Dry mouth—Docetaxel—ovarian cancer	0.00132	0.00132	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.00132	0.00132	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00131	0.00132	CcSEcCtD
Milnacipran—Fatigue—Paclitaxel—ovarian cancer	0.00131	0.00131	CcSEcCtD
Milnacipran—Pollakiuria—Doxorubicin—ovarian cancer	0.00131	0.00131	CcSEcCtD
Milnacipran—Constipation—Paclitaxel—ovarian cancer	0.0013	0.0013	CcSEcCtD
Milnacipran—Haematuria—Epirubicin—ovarian cancer	0.0013	0.0013	CcSEcCtD
Milnacipran—Hepatobiliary disease—Epirubicin—ovarian cancer	0.00129	0.00129	CcSEcCtD
Milnacipran—Infection—Docetaxel—ovarian cancer	0.00128	0.00128	CcSEcCtD
Milnacipran—Weight decreased—Doxorubicin—ovarian cancer	0.00128	0.00128	CcSEcCtD
Milnacipran—Levomilnacipran—ABCB1—ovarian cancer	0.00128	1	CrCbGaD
Milnacipran—Shock—Docetaxel—ovarian cancer	0.00127	0.00127	CcSEcCtD
Milnacipran—Nervous system disorder—Docetaxel—ovarian cancer	0.00127	0.00127	CcSEcCtD
Milnacipran—Thrombocytopenia—Docetaxel—ovarian cancer	0.00126	0.00127	CcSEcCtD
Milnacipran—Tachycardia—Docetaxel—ovarian cancer	0.00126	0.00126	CcSEcCtD
Milnacipran—Skin disorder—Docetaxel—ovarian cancer	0.00125	0.00126	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00125	0.00125	CcSEcCtD
Milnacipran—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00125	0.00125	CcSEcCtD
Milnacipran—Anorexia—Docetaxel—ovarian cancer	0.00123	0.00123	CcSEcCtD
Milnacipran—Urinary tract infection—Doxorubicin—ovarian cancer	0.00123	0.00123	CcSEcCtD
Milnacipran—Hepatitis—Epirubicin—ovarian cancer	0.00123	0.00123	CcSEcCtD
Milnacipran—Hypoaesthesia—Epirubicin—ovarian cancer	0.00122	0.00122	CcSEcCtD
Milnacipran—Urinary tract disorder—Epirubicin—ovarian cancer	0.00121	0.00121	CcSEcCtD
Milnacipran—Urticaria—Paclitaxel—ovarian cancer	0.00121	0.00121	CcSEcCtD
Milnacipran—Oedema peripheral—Epirubicin—ovarian cancer	0.00121	0.00121	CcSEcCtD
Milnacipran—Hypotension—Docetaxel—ovarian cancer	0.00121	0.00121	CcSEcCtD
Milnacipran—Haematuria—Doxorubicin—ovarian cancer	0.0012	0.00121	CcSEcCtD
Milnacipran—Connective tissue disorder—Epirubicin—ovarian cancer	0.0012	0.00121	CcSEcCtD
Milnacipran—Body temperature increased—Paclitaxel—ovarian cancer	0.0012	0.00121	CcSEcCtD
Milnacipran—Abdominal pain—Paclitaxel—ovarian cancer	0.0012	0.00121	CcSEcCtD
Milnacipran—Urethral disorder—Epirubicin—ovarian cancer	0.0012	0.0012	CcSEcCtD
Milnacipran—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.00119	0.0012	CcSEcCtD
Milnacipran—Insomnia—Docetaxel—ovarian cancer	0.00117	0.00117	CcSEcCtD
Milnacipran—Paraesthesia—Docetaxel—ovarian cancer	0.00116	0.00116	CcSEcCtD
Milnacipran—Erythema multiforme—Epirubicin—ovarian cancer	0.00116	0.00116	CcSEcCtD
Milnacipran—Dyspnoea—Docetaxel—ovarian cancer	0.00115	0.00115	CcSEcCtD
Milnacipran—Somnolence—Docetaxel—ovarian cancer	0.00115	0.00115	CcSEcCtD
Milnacipran—Eye disorder—Epirubicin—ovarian cancer	0.00115	0.00115	CcSEcCtD
Milnacipran—Flushing—Epirubicin—ovarian cancer	0.00114	0.00114	CcSEcCtD
Milnacipran—Cardiac disorder—Epirubicin—ovarian cancer	0.00114	0.00114	CcSEcCtD
Milnacipran—Dyspepsia—Docetaxel—ovarian cancer	0.00114	0.00114	CcSEcCtD
Milnacipran—Hepatitis—Doxorubicin—ovarian cancer	0.00113	0.00114	CcSEcCtD
Milnacipran—Hypoaesthesia—Doxorubicin—ovarian cancer	0.00113	0.00113	CcSEcCtD
Milnacipran—Decreased appetite—Docetaxel—ovarian cancer	0.00112	0.00112	CcSEcCtD
Milnacipran—Hypersensitivity—Paclitaxel—ovarian cancer	0.00112	0.00112	CcSEcCtD
Milnacipran—Urinary tract disorder—Doxorubicin—ovarian cancer	0.00112	0.00112	CcSEcCtD
Milnacipran—Oedema peripheral—Doxorubicin—ovarian cancer	0.00112	0.00112	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00111	0.00112	CcSEcCtD
Milnacipran—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00111	0.00112	CcSEcCtD
Milnacipran—Fatigue—Docetaxel—ovarian cancer	0.00111	0.00111	CcSEcCtD
Milnacipran—Angiopathy—Epirubicin—ovarian cancer	0.00111	0.00111	CcSEcCtD
Milnacipran—Urethral disorder—Doxorubicin—ovarian cancer	0.00111	0.00111	CcSEcCtD
Milnacipran—Mediastinal disorder—Epirubicin—ovarian cancer	0.0011	0.00111	CcSEcCtD
Milnacipran—Constipation—Docetaxel—ovarian cancer	0.0011	0.00111	CcSEcCtD
Milnacipran—Chills—Epirubicin—ovarian cancer	0.0011	0.0011	CcSEcCtD
Milnacipran—Asthenia—Paclitaxel—ovarian cancer	0.00109	0.00109	CcSEcCtD
Milnacipran—Pruritus—Paclitaxel—ovarian cancer	0.00108	0.00108	CcSEcCtD
Milnacipran—Mental disorder—Epirubicin—ovarian cancer	0.00107	0.00107	CcSEcCtD
Milnacipran—Erythema multiforme—Doxorubicin—ovarian cancer	0.00107	0.00107	CcSEcCtD
Milnacipran—Malnutrition—Epirubicin—ovarian cancer	0.00107	0.00107	CcSEcCtD
Milnacipran—Eye disorder—Doxorubicin—ovarian cancer	0.00106	0.00106	CcSEcCtD
Milnacipran—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00106	0.00106	CcSEcCtD
Milnacipran—Flushing—Doxorubicin—ovarian cancer	0.00105	0.00105	CcSEcCtD
Milnacipran—Cardiac disorder—Doxorubicin—ovarian cancer	0.00105	0.00105	CcSEcCtD
Milnacipran—Flatulence—Epirubicin—ovarian cancer	0.00105	0.00105	CcSEcCtD
Milnacipran—Tension—Epirubicin—ovarian cancer	0.00105	0.00105	CcSEcCtD
Milnacipran—Dysgeusia—Epirubicin—ovarian cancer	0.00104	0.00105	CcSEcCtD
Milnacipran—Diarrhoea—Paclitaxel—ovarian cancer	0.00104	0.00104	CcSEcCtD
Milnacipran—Angiopathy—Doxorubicin—ovarian cancer	0.00103	0.00103	CcSEcCtD
Milnacipran—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00102	0.00102	CcSEcCtD
Milnacipran—Abdominal pain—Docetaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Milnacipran—Body temperature increased—Docetaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Milnacipran—Chills—Doxorubicin—ovarian cancer	0.00102	0.00102	CcSEcCtD
Milnacipran—Dizziness—Paclitaxel—ovarian cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Vision blurred—Epirubicin—ovarian cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Mental disorder—Doxorubicin—ovarian cancer	0.000993	0.000994	CcSEcCtD
Milnacipran—Malnutrition—Doxorubicin—ovarian cancer	0.000987	0.000988	CcSEcCtD
Milnacipran—Agitation—Epirubicin—ovarian cancer	0.00098	0.000981	CcSEcCtD
Milnacipran—Flatulence—Doxorubicin—ovarian cancer	0.000972	0.000974	CcSEcCtD
Milnacipran—Tension—Doxorubicin—ovarian cancer	0.000968	0.00097	CcSEcCtD
Milnacipran—Vomiting—Paclitaxel—ovarian cancer	0.000968	0.000969	CcSEcCtD
Milnacipran—Dysgeusia—Doxorubicin—ovarian cancer	0.000966	0.000968	CcSEcCtD
Milnacipran—Rash—Paclitaxel—ovarian cancer	0.00096	0.000961	CcSEcCtD
Milnacipran—Dermatitis—Paclitaxel—ovarian cancer	0.000959	0.00096	CcSEcCtD
Milnacipran—Syncope—Epirubicin—ovarian cancer	0.000956	0.000958	CcSEcCtD
Milnacipran—Leukopenia—Epirubicin—ovarian cancer	0.000955	0.000956	CcSEcCtD
Milnacipran—Headache—Paclitaxel—ovarian cancer	0.000954	0.000955	CcSEcCtD
Milnacipran—Hypersensitivity—Docetaxel—ovarian cancer	0.000951	0.000952	CcSEcCtD
Milnacipran—Palpitations—Epirubicin—ovarian cancer	0.000943	0.000944	CcSEcCtD
Milnacipran—Loss of consciousness—Epirubicin—ovarian cancer	0.000937	0.000939	CcSEcCtD
Milnacipran—Vision blurred—Doxorubicin—ovarian cancer	0.00093	0.000931	CcSEcCtD
Milnacipran—Asthenia—Docetaxel—ovarian cancer	0.000926	0.000927	CcSEcCtD
Milnacipran—Convulsion—Epirubicin—ovarian cancer	0.000924	0.000925	CcSEcCtD
Milnacipran—Hypertension—Epirubicin—ovarian cancer	0.000921	0.000922	CcSEcCtD
Milnacipran—Pruritus—Docetaxel—ovarian cancer	0.000913	0.000914	CcSEcCtD
Milnacipran—Chest pain—Epirubicin—ovarian cancer	0.000908	0.000909	CcSEcCtD
Milnacipran—Agitation—Doxorubicin—ovarian cancer	0.000907	0.000908	CcSEcCtD
Milnacipran—Anxiety—Epirubicin—ovarian cancer	0.000905	0.000906	CcSEcCtD
Milnacipran—Nausea—Paclitaxel—ovarian cancer	0.000904	0.000906	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000902	0.000903	CcSEcCtD
Milnacipran—Dry mouth—Epirubicin—ovarian cancer	0.000888	0.000889	CcSEcCtD
Milnacipran—Syncope—Doxorubicin—ovarian cancer	0.000885	0.000886	CcSEcCtD
Milnacipran—Leukopenia—Doxorubicin—ovarian cancer	0.000883	0.000885	CcSEcCtD
Milnacipran—Diarrhoea—Docetaxel—ovarian cancer	0.000883	0.000884	CcSEcCtD
Milnacipran—Palpitations—Doxorubicin—ovarian cancer	0.000872	0.000873	CcSEcCtD
Milnacipran—Loss of consciousness—Doxorubicin—ovarian cancer	0.000867	0.000869	CcSEcCtD
Milnacipran—Infection—Epirubicin—ovarian cancer	0.000865	0.000866	CcSEcCtD
Milnacipran—Shock—Epirubicin—ovarian cancer	0.000856	0.000858	CcSEcCtD
Milnacipran—Convulsion—Doxorubicin—ovarian cancer	0.000855	0.000856	CcSEcCtD
Milnacipran—Nervous system disorder—Epirubicin—ovarian cancer	0.000854	0.000855	CcSEcCtD
Milnacipran—Dizziness—Docetaxel—ovarian cancer	0.000853	0.000855	CcSEcCtD
Milnacipran—Thrombocytopenia—Epirubicin—ovarian cancer	0.000852	0.000853	CcSEcCtD
Milnacipran—Hypertension—Doxorubicin—ovarian cancer	0.000852	0.000853	CcSEcCtD
Milnacipran—Tachycardia—Epirubicin—ovarian cancer	0.00085	0.000851	CcSEcCtD
Milnacipran—Skin disorder—Epirubicin—ovarian cancer	0.000846	0.000847	CcSEcCtD
Milnacipran—Hyperhidrosis—Epirubicin—ovarian cancer	0.000842	0.000843	CcSEcCtD
Milnacipran—Chest pain—Doxorubicin—ovarian cancer	0.00084	0.000841	CcSEcCtD
Milnacipran—Anxiety—Doxorubicin—ovarian cancer	0.000837	0.000838	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000834	0.000835	CcSEcCtD
Milnacipran—Anorexia—Epirubicin—ovarian cancer	0.00083	0.000831	CcSEcCtD
Milnacipran—Dry mouth—Doxorubicin—ovarian cancer	0.000822	0.000823	CcSEcCtD
Milnacipran—Vomiting—Docetaxel—ovarian cancer	0.000821	0.000822	CcSEcCtD
Milnacipran—Rash—Docetaxel—ovarian cancer	0.000814	0.000815	CcSEcCtD
Milnacipran—Hypotension—Epirubicin—ovarian cancer	0.000813	0.000814	CcSEcCtD
Milnacipran—Dermatitis—Docetaxel—ovarian cancer	0.000813	0.000814	CcSEcCtD
Milnacipran—Headache—Docetaxel—ovarian cancer	0.000808	0.00081	CcSEcCtD
Milnacipran—Infection—Doxorubicin—ovarian cancer	0.0008	0.000801	CcSEcCtD
Milnacipran—Shock—Doxorubicin—ovarian cancer	0.000792	0.000793	CcSEcCtD
Milnacipran—Nervous system disorder—Doxorubicin—ovarian cancer	0.00079	0.000791	CcSEcCtD
Milnacipran—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000789	0.00079	CcSEcCtD
Milnacipran—Insomnia—Epirubicin—ovarian cancer	0.000787	0.000788	CcSEcCtD
Milnacipran—Tachycardia—Doxorubicin—ovarian cancer	0.000786	0.000787	CcSEcCtD
Milnacipran—Skin disorder—Doxorubicin—ovarian cancer	0.000782	0.000783	CcSEcCtD
Milnacipran—Paraesthesia—Epirubicin—ovarian cancer	0.000782	0.000783	CcSEcCtD
Milnacipran—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000779	0.00078	CcSEcCtD
Milnacipran—Dyspnoea—Epirubicin—ovarian cancer	0.000776	0.000777	CcSEcCtD
Milnacipran—Somnolence—Epirubicin—ovarian cancer	0.000774	0.000775	CcSEcCtD
Milnacipran—Anorexia—Doxorubicin—ovarian cancer	0.000768	0.000769	CcSEcCtD
Milnacipran—Nausea—Docetaxel—ovarian cancer	0.000767	0.000768	CcSEcCtD
Milnacipran—Dyspepsia—Epirubicin—ovarian cancer	0.000766	0.000767	CcSEcCtD
Milnacipran—Decreased appetite—Epirubicin—ovarian cancer	0.000757	0.000758	CcSEcCtD
Milnacipran—Hypotension—Doxorubicin—ovarian cancer	0.000753	0.000754	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000752	0.000752	CcSEcCtD
Milnacipran—Fatigue—Epirubicin—ovarian cancer	0.00075	0.000751	CcSEcCtD
Milnacipran—Constipation—Epirubicin—ovarian cancer	0.000744	0.000745	CcSEcCtD
Milnacipran—Insomnia—Doxorubicin—ovarian cancer	0.000728	0.000729	CcSEcCtD
Milnacipran—Paraesthesia—Doxorubicin—ovarian cancer	0.000723	0.000724	CcSEcCtD
Milnacipran—Dyspnoea—Doxorubicin—ovarian cancer	0.000718	0.000719	CcSEcCtD
Milnacipran—Somnolence—Doxorubicin—ovarian cancer	0.000716	0.000717	CcSEcCtD
Milnacipran—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000712	0.000713	CcSEcCtD
Milnacipran—Dyspepsia—Doxorubicin—ovarian cancer	0.000709	0.00071	CcSEcCtD
Milnacipran—Decreased appetite—Doxorubicin—ovarian cancer	0.0007	0.000701	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000695	0.000696	CcSEcCtD
Milnacipran—Fatigue—Doxorubicin—ovarian cancer	0.000694	0.000695	CcSEcCtD
Milnacipran—Urticaria—Epirubicin—ovarian cancer	0.000692	0.000692	CcSEcCtD
Milnacipran—Constipation—Doxorubicin—ovarian cancer	0.000689	0.00069	CcSEcCtD
Milnacipran—Body temperature increased—Epirubicin—ovarian cancer	0.000688	0.000689	CcSEcCtD
Milnacipran—Abdominal pain—Epirubicin—ovarian cancer	0.000688	0.000689	CcSEcCtD
Milnacipran—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000659	0.000659	CcSEcCtD
Milnacipran—Hypersensitivity—Epirubicin—ovarian cancer	0.000641	0.000642	CcSEcCtD
Milnacipran—Urticaria—Doxorubicin—ovarian cancer	0.00064	0.000641	CcSEcCtD
Milnacipran—Body temperature increased—Doxorubicin—ovarian cancer	0.000637	0.000638	CcSEcCtD
Milnacipran—Abdominal pain—Doxorubicin—ovarian cancer	0.000637	0.000638	CcSEcCtD
Milnacipran—Asthenia—Epirubicin—ovarian cancer	0.000625	0.000625	CcSEcCtD
Milnacipran—Pruritus—Epirubicin—ovarian cancer	0.000616	0.000617	CcSEcCtD
Milnacipran—Diarrhoea—Epirubicin—ovarian cancer	0.000596	0.000596	CcSEcCtD
Milnacipran—Hypersensitivity—Doxorubicin—ovarian cancer	0.000593	0.000594	CcSEcCtD
Milnacipran—Asthenia—Doxorubicin—ovarian cancer	0.000578	0.000579	CcSEcCtD
Milnacipran—Dizziness—Epirubicin—ovarian cancer	0.000576	0.000576	CcSEcCtD
Milnacipran—Pruritus—Doxorubicin—ovarian cancer	0.00057	0.000571	CcSEcCtD
Milnacipran—Vomiting—Epirubicin—ovarian cancer	0.000553	0.000554	CcSEcCtD
Milnacipran—Diarrhoea—Doxorubicin—ovarian cancer	0.000551	0.000552	CcSEcCtD
Milnacipran—Rash—Epirubicin—ovarian cancer	0.000549	0.00055	CcSEcCtD
Milnacipran—Dermatitis—Epirubicin—ovarian cancer	0.000548	0.000549	CcSEcCtD
Milnacipran—Headache—Epirubicin—ovarian cancer	0.000545	0.000546	CcSEcCtD
Milnacipran—Dizziness—Doxorubicin—ovarian cancer	0.000533	0.000533	CcSEcCtD
Milnacipran—Nausea—Epirubicin—ovarian cancer	0.000517	0.000518	CcSEcCtD
Milnacipran—Vomiting—Doxorubicin—ovarian cancer	0.000512	0.000513	CcSEcCtD
Milnacipran—Rash—Doxorubicin—ovarian cancer	0.000508	0.000508	CcSEcCtD
Milnacipran—Dermatitis—Doxorubicin—ovarian cancer	0.000507	0.000508	CcSEcCtD
Milnacipran—Headache—Doxorubicin—ovarian cancer	0.000505	0.000505	CcSEcCtD
Milnacipran—Nausea—Doxorubicin—ovarian cancer	0.000478	0.000479	CcSEcCtD
